Chronic Benign Tubular Albuminuria From Compound Heterozygous Variants in CUBN: A Case Report.

IF 1.6 Q3 UROLOGY & NEPHROLOGY
Canadian Journal of Kidney Health and Disease Pub Date : 2025-02-05 eCollection Date: 2025-01-01 DOI:10.1177/20543581251317016
Adam Pietrobon, Mark D Elliott
{"title":"Chronic Benign Tubular Albuminuria From Compound Heterozygous Variants in <i>CUBN</i>: A Case Report.","authors":"Adam Pietrobon, Mark D Elliott","doi":"10.1177/20543581251317016","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Albuminuria is a commonly used parameter for predicting decline in kidney filtration function. Cubilin, encoded by <i>CUBN</i>, is a critical protein involved in protein reabsorption in the proximal tubule. Mutations in <i>CUBN</i> lead to Imerslund-Gräsbeck syndrome (IGS), a disorder characterized by vitamin B12 deficiency (and consequences related to that) with or without albuminuria. Recent evidence suggests that C-terminal variants in <i>CUBN</i> may lead to albuminuria without other features of IGS.</p><p><strong>Presenting concerns of the patient: </strong>Here, we report a case of a 52-year-old male with chronic, albumin-predominant, subnephrotic range proteinuria since his teenage years, but preserved estimated glomerular filtration rate (eGFR).</p><p><strong>Interventions: </strong>Neither angiotensin-converting enzyme (ACE) inhibition nor angiotensin Type II (AT-II) receptor blockade reduced his degree of albuminuria.</p><p><strong>Diagnosis: </strong>Genetic testing identified 3 distinct pathogenic variants in <i>CUBN</i> that were confirmed by segregation analysis to be a compound heterozygous mode of inheritance. All variants were downstream of the intrinsic factor-vitamin B12 binding domain of cubilin. The patient had normal vitamin B12 levels and did not exhibit any features of IGS.</p><p><strong>Outcomes: </strong>Kidney biopsy was not pursued for this patient as diagnostic clarification was achieved by non-invasive genetic testing alone.</p><p><strong>Novel findings: </strong>This case highlights several important lessons. First, not all albuminuria is made equal, and forms of tubular albuminuria can exist without compromising kidney filtration function. Second, identifying genetic forms of tubular albuminuria is key to avoiding ineffective interventions (eg, ACE inhibition, AT-II receptor blockade, sodium-glucose cotransporter-2 [SGLT2] inhibition) and unnecessary invasive procedures (eg, kidney biopsy). Third, the location of <i>CUBN</i> variants dictates phenotypic consequences, with C-terminal variants leading to albuminuria without vitamin B12 deficiency.</p>","PeriodicalId":9426,"journal":{"name":"Canadian Journal of Kidney Health and Disease","volume":"12 ","pages":"20543581251317016"},"PeriodicalIF":1.6000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795617/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Kidney Health and Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20543581251317016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Albuminuria is a commonly used parameter for predicting decline in kidney filtration function. Cubilin, encoded by CUBN, is a critical protein involved in protein reabsorption in the proximal tubule. Mutations in CUBN lead to Imerslund-Gräsbeck syndrome (IGS), a disorder characterized by vitamin B12 deficiency (and consequences related to that) with or without albuminuria. Recent evidence suggests that C-terminal variants in CUBN may lead to albuminuria without other features of IGS.

Presenting concerns of the patient: Here, we report a case of a 52-year-old male with chronic, albumin-predominant, subnephrotic range proteinuria since his teenage years, but preserved estimated glomerular filtration rate (eGFR).

Interventions: Neither angiotensin-converting enzyme (ACE) inhibition nor angiotensin Type II (AT-II) receptor blockade reduced his degree of albuminuria.

Diagnosis: Genetic testing identified 3 distinct pathogenic variants in CUBN that were confirmed by segregation analysis to be a compound heterozygous mode of inheritance. All variants were downstream of the intrinsic factor-vitamin B12 binding domain of cubilin. The patient had normal vitamin B12 levels and did not exhibit any features of IGS.

Outcomes: Kidney biopsy was not pursued for this patient as diagnostic clarification was achieved by non-invasive genetic testing alone.

Novel findings: This case highlights several important lessons. First, not all albuminuria is made equal, and forms of tubular albuminuria can exist without compromising kidney filtration function. Second, identifying genetic forms of tubular albuminuria is key to avoiding ineffective interventions (eg, ACE inhibition, AT-II receptor blockade, sodium-glucose cotransporter-2 [SGLT2] inhibition) and unnecessary invasive procedures (eg, kidney biopsy). Third, the location of CUBN variants dictates phenotypic consequences, with C-terminal variants leading to albuminuria without vitamin B12 deficiency.

慢性良性小管性蛋白尿由复合杂合变异体引起:1例报告。
理由:蛋白尿是预测肾滤过功能下降的常用参数。Cubilin由CUBN编码,是参与近端小管蛋白重吸收的关键蛋白。CUBN的突变导致Imerslund-Gräsbeck综合征(IGS),这是一种以维生素B12缺乏(及其相关后果)为特征的疾病,伴有或不伴有蛋白尿。最近的证据表明,CUBN的c端变异可能导致蛋白尿,而不具有IGS的其他特征。患者的关注:在这里,我们报告一例52岁男性,从青少年时期开始患有慢性,白蛋白为主,亚肾病范围蛋白尿,但保留了估计的肾小球滤过率(eGFR)。干预措施:血管紧张素转换酶(ACE)抑制和血管紧张素II型(AT-II)受体阻断都不能降低他的蛋白尿程度。诊断:基因检测在CUBN中发现3种不同的致病变异,通过分离分析证实为复合杂合遗传模式。所有变异都位于cubilin的内在因子-维生素B12结合域的下游。患者维生素B12水平正常,未表现出IGS的任何特征。结果:该患者未进行肾活检,因为仅通过非侵入性基因检测即可获得诊断澄清。新发现:这个案例突出了几个重要的教训。首先,不是所有的蛋白尿都是一样的,管状蛋白尿的形式可以存在而不损害肾脏过滤功能。其次,确定小管性蛋白尿的遗传形式是避免无效干预(如ACE抑制、AT-II受体阻断、钠-葡萄糖共转运体-2 [SGLT2]抑制)和不必要的侵入性手术(如肾活检)的关键。第三,CUBN变异的位置决定了表型后果,c端变异导致无维生素B12缺乏症的蛋白尿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
5.90%
发文量
84
审稿时长
12 weeks
期刊介绍: Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation. Our mandate is to promote and advocate for kidney health as it impacts national and international communities. Basic science, translational studies and clinical studies will be peer reviewed and processed by an Editorial Board comprised of geographically diverse Canadian and international nephrologists, internists and allied health professionals; this Editorial Board is mandated to ensure highest quality publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信